Decheng Capital — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Nuvation Bio is a global oncology company that develops novel cancer therapies through its own drug discovery programs and business development, serving cancer patients.
BiotechHealthtechNew York, US
David Hung(Founder)inDavid Hanley(Chief Technical Operations Officer)inGary Hattersley(Chief Scientific Officer)inStacy Markel(Chief People Officer)inPhilippe Sauvage(Chief Financial Officer)inColleen Sjogren(Chief Commercial Officer)in
Co-investorsAisling CapitalEcoR1 CapitalVertex Ventures ChinaOmega Funds
A biopharmaceutical company developing targeted cancer drugs and related therapies.
BiotechHealthtechMedical DevicesShanghai, CN
Co-investorsQiming Venture PartnersLilly Asia Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






